Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.23.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   23,665,991    
Beginning balance at Dec. 31, 2021 $ 48,787 $ 237 $ 182,482 $ (133,932)
Issuances of common stock:        
Share-based compensation (in shares)   29,916    
Share-based compensation 899   899  
Warrant and option exercises (cash and cashless) (in shares)   12,211    
Warrant and option exercises (cash and cashless) 3   3  
Net loss for the period (3,959)     (3,959)
Ending balance (in shares) at Mar. 31, 2022   23,708,118    
Ending balance at Mar. 31, 2022 45,730 $ 237 183,384 (137,891)
Beginning balance (in shares) at Dec. 31, 2021   23,665,991    
Beginning balance at Dec. 31, 2021 48,787 $ 237 182,482 (133,932)
Issuances of common stock:        
Net loss for the period (8,262)      
Ending balance (in shares) at Jun. 30, 2022   24,480,600    
Ending balance at Jun. 30, 2022 42,820 $ 245 184,769 (142,194)
Beginning balance (in shares) at Mar. 31, 2022   23,708,118    
Beginning balance at Mar. 31, 2022 45,730 $ 237 183,384 (137,891)
Issuances of common stock:        
Share-based compensation (in shares)   379,122    
Share-based compensation 880 $ 4 876  
Warrant and option exercises (cash and cashless) (in shares)   367,006    
Warrant and option exercises (cash and cashless) 253 $ 4 249  
Issuance of common stock under employee stock purchase plan (in shares)   26,354    
Issuance of common stock under employee stock purchase plan 260   260  
Net loss for the period (4,303)     (4,303)
Ending balance (in shares) at Jun. 30, 2022   24,480,600    
Ending balance at Jun. 30, 2022 $ 42,820 $ 245 184,769 (142,194)
Beginning balance (in shares) at Dec. 31, 2022 24,578,983 24,578,983    
Beginning balance at Dec. 31, 2022 $ 36,887 $ 246 187,008 (150,367)
Issuances of common stock:        
Share-based compensation (in shares)   3,782    
Share-based compensation 1,307   1,307  
Payments for taxes related to net share settlement of equity awards (in shares)   (514)    
Payments for taxes related to net share settlement of equity awards (5)   (5)  
Net loss for the period (5,609)     (5,609)
Ending balance (in shares) at Mar. 31, 2023   24,582,251    
Ending balance at Mar. 31, 2023 $ 32,580 $ 246 188,310 (155,976)
Beginning balance (in shares) at Dec. 31, 2022 24,578,983 24,578,983    
Beginning balance at Dec. 31, 2022 $ 36,887 $ 246 187,008 (150,367)
Issuances of common stock:        
Net loss for the period $ (12,661)      
Ending balance (in shares) at Jun. 30, 2023 24,627,674 24,627,674    
Ending balance at Jun. 30, 2023 $ 27,410 $ 246 190,192 (163,028)
Beginning balance (in shares) at Mar. 31, 2023   24,582,251    
Beginning balance at Mar. 31, 2023 32,580 $ 246 188,310 (155,976)
Issuances of common stock:        
Share-based compensation (in shares)   5,484    
Share-based compensation 1,645   1,645  
Payments for taxes related to net share settlement of equity awards (in shares)   (11,102)    
Payments for taxes related to net share settlement of equity awards (77)   (77)  
Issuance of common stock under employee stock purchase plan (in shares)   51,041    
Issuance of common stock under employee stock purchase plan 314   314  
Net loss for the period $ (7,052)     (7,052)
Ending balance (in shares) at Jun. 30, 2023 24,627,674 24,627,674    
Ending balance at Jun. 30, 2023 $ 27,410 $ 246 $ 190,192 $ (163,028)